Mixed Topics
From the Journals
Many Patients With Cancer Visit EDs Before Diagnosis
Factors associated with an increased likelihood of an ED visit ahead of diagnosis included having certain cancers, living in rural areas, and...
From the Journals
Plasma Omega-6 and Omega-3 Fatty Acids Inversely Associated With Cancer
The findings support possible small net protective roles of omega-3 and omega-6 PUFAs in the development of new cancer incidence, the researchers...
From the Journals
Industry Payments to Peer Reviewers Scrutinized at Four Major Medical Journals
Major medical journals relied on peer reviewers who received more than $64 million in non-research payments between 2020 and 2022.
Feature
Cannabis in Cancer: What Oncologists and Patients Should Know
Access to and use of cannabis alongside cancer care have outpaced the science on evidence-based indications, according to an ASCO expert panel.
From the Journals
Crisugabalin Alleviates Postherpetic Neuralgia Symptoms in Phase 3 Study
“Crisugabalin 40 mg/d or crisugabalin 80 mg/d was well tolerated and significantly improved ADPS compared to placebo.”
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
From the Journals
Cancer Risk: Are Pesticides the New Smoking?
A recent study evaluated cancer risks in the US population using a model that accounts for pesticide use and adjusts for various factors.
Latest News
Neurofibromatosis: What Affects Quality of Life Most?
“To develop effective therapeutics, meaningful clinical outcomes that are tied with improvement in QoL for persons with NF1 must be clearly...
From the Journals
Cancer Cases, Deaths in Men Predicted to Surge by 2050
Researchers analyzed data from the 2022 Global Cancer Observatory (GLOBOCAN), which provides national-level estimates for cancer cases and deaths...
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.